Frankfurt - Delayed Quote EUR
GenSight Biologics S.A. (G49N.F)
0.2095
-0.0230
(-9.89%)
As of 8:19:17 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-12,937
-12,937
-24,663
-33,753
-17,139
Investing Cash Flow
17
17
209
172
-16
Financing Cash Flow
13,542
13,542
15,859
95
23,739
End Cash Position
2,464
2,464
2,134
10,610
44,288
Capital Expenditure
-1
-1
-10
-252
-32
Issuance of Capital Stock
16,742
16,742
4,017
38
439
Issuance of Debt
--
--
14,182
10,800
--
Repayment of Debt
-2,153
-2,153
-1,081
-7,822
-3,069
Repurchase of Capital Stock
-27
-27
-99
-193
-305
Free Cash Flow
-12,938
-12,938
-24,673
-34,005
-17,171
12/31/2021 - 7/14/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade